Clinical Trials Logo

Clinical Trial Summary

Patients with established cardiovascular disease (CVD) often have multiple medications that increase the risk of prevalence of drug therapy problems (DTP), subsequently leading to unfavourable clinical and health outcomes. By providing Comprehensive Medication Management (CMM) services to patients within a healthcare system, pharmacists assess patients' medication-related needs, identify and prevent DTP, develop individualized care plan for each individual patient and evaluate and monitor outcomes. Thus, the CMM services delivered at the primary care level in collaboration with general practitioners and other healthcare providers could address this problem and by optimizing therapy improve patients' clinical outcomes and quality of life. Studies have shown that patients with chronic diseases have the greatest benefit from the CMM services. The aim of this study is to evaluate the impact of CMM services on clinical and humanistic outcomes in patients with established CVD. The study will employ prospective, longitudinal, pre- and postintervention study with a 1-year patient follow-up.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT04778891
Study type Interventional
Source University of Zagreb
Status Completed
Phase N/A
Start date January 8, 2018
Completion date January 17, 2021

See also
  Status Clinical Trial Phase
Completed NCT03334565 - Reducing PM-associated CV Health Effects for Seniors N/A
Recruiting NCT04291690 - The TARGET-EFT Trial N/A
Recruiting NCT03895541 - Noninvasive Elastography Evaluation of Myocardial Stiffness in Elderly Patients With Isolated Diastolic Heart Failure: New Diagnostic Tool? N/A